SYN010(Synbufo, Budesonide+Formoterol)
SYN010 (Synbufo, Budesonide+Formoterol) is a combinational product with inhaled corticosteroid and long acting beta-2 agonist (ICS+LABA) and have a similar formulation to the Symbicort. It acquired license certificate in Taiwan in 2022. The global clinical study is proceeding and international submission dossier is under preparation.
Drug Information
https://info.fda.gov.tw/MLMS/H0001D.aspx?Type=Lic&LicId=51061164